Bausch Health Companies (BHC) Cash from Investing Activities (2009 - 2026)

Bausch Health Companies has reported Cash from Investing Activities for 18 years, with the latest figure at -$93.0 million in Q2 2026.

• Quarterly Cash from Investing Activities rose 7.0% year-over-year to -$93.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$597.0 million (down 12.22% YoY) and the FY2025 annual result came in at -$595.0 million, down 31.06% from the prior year.
• Cash from Investing Activities climbed to -$93.0 million in Q2 2026 per BHC's latest filing, from -$139.0 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$30.0 million in Q2 2023 and troughed at -$1.9 billion in Q3 2023.
• A 5-year average of -$207.2 million and a median of -$96.5 million in 2025 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities plunged 3464.15% in 2023, then soared 94.6% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$136.0 million in 2022, then fell by 8.82% to -$148.0 million in 2023, then sank by 35.14% to -$200.0 million in 2024, then slumped by 41.0% to -$282.0 million in 2025, then surged by 67.02% to -$93.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$93.0 million, -$139.0 million, and -$282.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.